phenergan prescription Movers in Rayno Diagnostics and Tools Stocks

On a lackluster day in the market two of our picks were up big,two others exceeded one year highs.

lumigan buy online familiarize Illumina (ILMN $81) was up 10% on earnings to an all time high recovering from its downdraft in 2011. Revenues were up 23% from previous quarter in 2012 and GAAP income was $36 M or $0.26 per share. Free cash flow was $77M for Q2. Illumina raised their expectations for 2013.

ascertain claritin cost Response Genetics (RGDX $2.13) was up 11% on huge volume of 563k shares with an average volume of 57k shares.There was no news so we can assume that a fund or an individual has added to their position. The Company has been in a turnaround mode with a recent financing and an emphasis on boosting sales of its predictive tests of  tumor response for various types of cancer. Revenues for the year are estimated at $22 M. Here is what we wrote on May 15,2013:

Emerging Biomarker Companies Redux: Positioned For Growth – Seeking Alpha

Also up today in the Rayno DX Portfolio are :

Alere ( substantiate provigil cost ALR $28.6) up 1.9% and a one year high.

Sequenom ( http://www.urbanpro.co/89669-buy-ashwagandha.html deliver SQNM $4.68) up 3.66%

Thermo Fisher ( TMO $90.76) up 1.4% at an all time high

We will be attending the AACC (American Association of Clinical Chemistry) Meeting in Houston next week and will provide an update on many of our focus stocks.

 

 

 

 

Pin It on Pinterest